bringing validated drug delivery technologies to cannabinoids.

Our exclusive, patented technologies incorporate years of drug-development research and are validated through their use in FDA-approved products. These technologies will make us the first cannabinoid-focused biopharmaceutical company to offer precision-dosing, high bioavailability and predictable, rapid absorption with every treatment.

Inhaled Dry Powder

CANNABINOID PRODUCT CANDIDATES

Based on a best-in-class inhaled drug delivery platform, these product candidates combine a simple-to-use, breath-powered inhaler and cannabinoid dry powder formulations. Intended to provide ultra-rapid, precise and discreet delivery of cannabinoid medicines to the lung, without the need for heating or combustion.

The product images shown are for illustration purposes only and may not be an exact representation of the product.

Oral Dosage Forms

CANNABINOID PRODUCT CANDIDATES

These product candidates are powered by an FDA-approved absorption-enhancing excipient that facilitates rapid drug absorption from the GI tract and increases bioavailability. Cannabinoids can be formulated as tablets, capsules or liquid solutions.

The product images shown are for illustration purposes only and may not be an exact representation of the product.